119 related articles for article (PubMed ID: 28895610)
1. Cancer vaccines using supramolecular hydrogels of NSAID-modified peptides as adjuvants abolish tumorigenesis.
Wang Z; Liang C; Shi F; He T; Gong C; Wang L; Yang Z
Nanoscale; 2017 Sep; 9(37):14058-14064. PubMed ID: 28895610
[TBL] [Abstract][Full Text] [Related]
2. A supramolecular protein chaperone for vaccine delivery.
Wang Z; Shang Y; Tan Z; Li X; Li G; Ren C; Wang F; Yang Z; Liu J
Theranostics; 2020; 10(2):657-670. PubMed ID: 31903143
[No Abstract] [Full Text] [Related]
3. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
[TBL] [Abstract][Full Text] [Related]
4. Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.
Masuko K; Wakita D; Togashi Y; Kita T; Kitamura H; Nishimura T
Immunol Lett; 2015 Jan; 163(1):102-12. PubMed ID: 25479286
[TBL] [Abstract][Full Text] [Related]
5. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
6. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod combined with dendritic cell vaccine decreases Treg proportion and enhances anti-tumor responses in mice bearing melanoma.
Ren S; Wang Q; Zhang Y; Lu C; Li P; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):145-50. PubMed ID: 29762000
[TBL] [Abstract][Full Text] [Related]
8. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
9. Amino acid sequence determines the adjuvant potency of a D-tetra-peptide hydrogel.
Zhang Y; Hu Z; Li X; Ding Y; Zhang Z; Zhang X; Zheng W; Yang Z
Biomater Sci; 2022 Jun; 10(12):3092-3098. PubMed ID: 35522938
[TBL] [Abstract][Full Text] [Related]
10. Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity.
Pogostin BH; Yu MH; Azares AR; Euliano EM; Lai CSE; Saenz G; Wu SX; Farsheed AC; Melhorn SM; Graf TP; Woodside DG; Hartgerink JD; McHugh KJ
Biomater Sci; 2022 Oct; 10(21):6217-6229. PubMed ID: 36102692
[TBL] [Abstract][Full Text] [Related]
11. A Fluorinated Supramolecular Self-Assembled Peptide as Nanovaccine Adjuvant for Enhanced Cancer Vaccine Therapy.
Jia S; Ji S; Zhao J; Lv Y; Wang J; Sun D; Ding D
Small Methods; 2023 May; 7(5):e2201409. PubMed ID: 36802205
[TBL] [Abstract][Full Text] [Related]
12. Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses.
Highton AJ; Girardin A; Bell GM; Hook SM; Kemp RA
BMC Immunol; 2016 Oct; 17(1):39. PubMed ID: 27756214
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous vaccination using injectable biodegradable hydrogels for long-term immune response.
Lee ALZ; Yang C; Gao S; Hedrick JL; Yang YY
Nanomedicine; 2019 Oct; 21():102056. PubMed ID: 31336176
[TBL] [Abstract][Full Text] [Related]
14. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
[TBL] [Abstract][Full Text] [Related]
15. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
[TBL] [Abstract][Full Text] [Related]
16. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
17. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
18. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
Okazaki S; Iwasaki T; Yuba E; Watarai S
J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
